Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Resverlogix Corp

+ Add to Watchlist


1.6300 CAD 0.0800 5.16%

As of 15:59:55 ET on 03/27/2015.

Company Profile for Resverlogix Corp (RVX)

Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.

Contact Information

Resverlogix Corp

202, 279 Midpark Way SE
Calgary, AB T2X 1M2
Phone: 1-403-254-9252
Fax: 1-403-256-8495

Key Executives for Resverlogix Corp (RVX)

Donald J McCaffreyPresident/CEO/SecretaryAaron Bradley Cann "Brad"Chief Financial Officer
Norman WongChief Scientific OfficerKenneth LebiodaSenior VP:Bus & Corporate Dev
Jan O JohanssonSenior VP:Medical Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil